Skip to content

Current ratio at other companies

AdaptHealth logo
AdaptHealthAHCO
0.9×-0.4×
Evolent Health, Inc. logo
Evolent Health, Inc.EVH
1.3×+0.3×
The Pennant Group, Inc. logo
The Pennant Group, Inc.PNTG
1.2×-0.2×
ResMed logo
ResMedRMD
-0.4×
UFP Technologies logo
UFP TechnologiesUFPT
2.9×+0.3×
Merit Medical Systems logo
Merit Medical SystemsMMSI
5.1×+0.2×

Other financials

Income statement

See full
Revenue$75.4M+27.5%
Gross profit$42.8M+28.7%
Operating income$4.3M+11.8%
Net income$2.6M-1.6%
EPS (diluted)$0.060.0%

Balance sheet

See full
Cash & equivalents$9.8M-3.9%
Total debt$12.4M+84.0%
Total equity$143.9M+6.8%
Total assets$197.4M+10.8%

Cash flow

See full
Operating cash flow$8.1M+183%
CapEx$6.7M-56.6%
Free cash flow$1.4M+111%

Valuation

See full
Market cap$448.16M+71.3%
Enterprise value$450.83M+74.6%
P/E30.1×+8.8×
P/S1.6×+0.4×

Profitability

See full
Gross margin57.6%-1.1pp
Operating margin8.2%-0.2pp
Net margin5.2%-0.1pp
FCF margin9%

Returns & leverage

See full
Return on equity10.7%+0.9pp
Debt / equity0.1×0.0×

Where this comes from

Calculated from Viemed Healthcare, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Viemed Healthcare, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viemed Healthcare, Inc.'s current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viemed Healthcare, Inc.'s current ratio?
Viemed Healthcare, Inc. (VMD) reported current ratio of 1.2× in Q1 2026.
How has Viemed Healthcare, Inc.'s current ratio changed year-over-year?
Viemed Healthcare, Inc.'s current ratio decreased by 11.6% year-over-year, from 1.4× to 1.2×.
What is the long-term trend for Viemed Healthcare, Inc.'s current ratio?
Over 5 years (2020 to 2025), Viemed Healthcare, Inc.'s current ratio has grown at a -10.4% compound annual growth rate (CAGR), from 2× to 1.2×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.